Evaluation of 'national drug strategies' in Europe

Introduction

Many countries have recently adopted a ‘national drugs strategy’. This Selected issue focuses on plans for the evaluation of these strategies, which for the first time has been enabled on a European scale by work undertaken by the national focal points. This work has helped to clarify references to evaluation in ‘national drugs strategies’, which are not always self-explanatory or clear-cut.

Table of contents

  • Approaches to measuring national drugs strategies
  • Evaluations: ‘ex ante’, ‘mid-term’ and ‘ex post’
  • Actors in the evaluation
  • Targets and indicators
  • Efficiency
  • Constraints on evaluation
Top